CD8A and type 2 diabetes mellitus: Studies have shown that CD8+T cells modulate pathological angiogenesis by promoting inflammation and chemokine recruitment in ocular neovascular diseases (59), and in type-2 diabetes, CD8+T cells’ plasticity regulates revascularization, ECs function, and angiogenesis (60).